---Ankebio start clinical study phase Ⅲ of Recombinant Human HER2 moloclonal antibody drug for Injection
---Construction of key laboratory of genetic engineering pharmacy in Anhui Province was approved
---Ankebio's production application of Growth hormone liquid for injection was accepted
---PersonGen Anke's CAR-T application for clinical trials of new drugs was accepted
---Anhui Anke Hengyi Pharmaceutical co.,Ltd received the notice of drug registration acceptance
---Anterferon passes review of Anhui province famous brand product
---Ankebio and its two subsidiaries were recognized as high-tech enterprises
---Ankebio's a preparation method of high purity Recombinant human interferon Alpha 2b and a method for the preparation of high purity tenofovir dipifuroxime fumarate" have obtained national invention patent
---Ankebio formally established the translational medicine center
---Ankebio holds a precision medicine seminar
---An academician workstation of Ankebio has been approved
---Ankebio successfully developed an anti-cancer drug recombinant human HER2 monoclonal antibody drug
---Ankebio accepts pd-1 humanized antibodies and related technologies
---"A type of Recombinant human interferon alpha 2b formulation" was awarded China patent excellence award and the fourth Anhui patent gold award
---First listed in the "top ten companies of China's GEM"
---160th anniversary of Anhui Anke Yuliangqing Pharmaceutical Co.,Ltd
---Anhui Anke Hengyi Pharmaceutical co.,Ltd was recognized as a national high-tech enterprise
---10th anniversary of AGCU ScienTech Incorporation
---Important progress has been made by PersonGen Biomedicine (suzhou) co. LTD in the treatment of T-cell lymphoma
---CAR-T therapy of PersonGen Anke was initially successful
---Ankebio holds the first Open Day event for employee family
---Ankebio wholly purchased Shanghai Soho-YiMing pharmaceuticals co. LTD
---Ankebio participation PersonGen Biomedicine (suzhou) co. LTD
---The wholly-owned subsidiary Anhui Anke YuLiangQing Pharmaceutical co.,ltd passed the national high and new technology enterprise recognition smoothly.
---Anke trademark has been identified as "well-known trademark of China".
---Ankebio's board won the title of "outstanding board of directors of China's gem listed companies in 2015"
---Ankebio again won the title of "tax credit grade A" enterprise
---"A kind of recombinant human interferon Alpha 2b formulation" won the fourth anhui province patent gold award
---Clinical research on growth hormone replacement therapy for adult growth hormone deficiency is initiated
---Ankebio holdings established Anhui xinhuakun biotechnology co., LTD., and introduced the national new biological product KGF-2 project
---Ankebio won the award of Third Anhui patent
---Chairman Song lihua was elected as a deputy to the 12th NPC
---The 20th anniversary celebration of Ankebio was successfully held
---The two development projects of long-term pegylated recombinant protein drug undertaken by anke biological have been accepted
---Ankebio recombinant human growth hormone injection obtained the invention patent
---Ankebio was identified as a national innovative pilot enterprise
---Ankebio has been formally certified by iso 9001:2008
---The project of " '' won the third prize of Anhui Province Science and Technology Award.
---Ankebio was rated as anhui province A - grade tax credit unit
---Ankebio was identified as "anhui province joint demonstration enterprise of production, education and research"
---Ankebio became the first batch of Chinese Second-board Market listed companies.
---Our Ansomone® / Recombianant Human Growth Hormone was granted "The Famous Reliable Brand of Anhui Province" by Anhui Bureau of Quality and Technical Supervision associated with Anhui Promotion of Famous Brands Committer.
--- Our Anterferon® / Recombianant Human Interferon a 2b was granted "The Famous Reliable Brand of Anhui Province" by Anhui Bureau of Quality and Technical Supervision associated with Anhui Promotion of Famous Brands Committer.
--- Our Anterferon® / Recombianant Human Interferon a 2b for Injection granted the Certificate of National New Drugs.
--- Our Anterferon® / Recombinant Human Interferon a 2b for Injection was approved for mass production.
---won the Special Prize of Science and Technology by Anhui Provincal Government.
--- Our Anterferon® / Recombinant Human Interferon a 2b Cream won IV-Class Certificate of National Novel Drugs awarded by Administration of Drugs Supervision.
--- The manufacturing plants of Anterferon® / Recombinant Human Interferon a 2b was approved by sFDA with GMP Certificate.
--- The manufacturing plants of Ansomone® / Recombination Human Growth Hormone was approved by sFDA with GMP Certificate.
--- Ansomone® / Recombinant Human Growth Hormone Project was approved and supported in China National Invention Funds Project
--- Anterferon® / Recombinant Human Interferon a 2b for Injection is granted the Certificate of National Key Novel Products and was approved and supported by China National Key Torch Project.
--- Anterferon ® / Recombination Human Interferon a 2b for injection was granted the certificate of National Novel Drugs and document of producing ratification (China II Class New Drug ).
---was awarded the prize of Development of technological Prize, III-Class by Anhui Provincial Government.
---Monoclonal Antibody Affinity Gel to a-interferon was granted the Certificate of National Novel Product.
---The study and application of Monoclonal Antibody Human Interferon a- was awarded
----The study and application of Monoclonal Antibody Human Interferon a was awarded.